Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol

Journal of Clinical Psychopharmacology
Julia KirchheinerJ Brockmöller

Abstract

The analgesic drug tramadol is bioactivated by CYP2D6 to the opioid receptor agonist O-desmethyltramadol. Case reports indicated that carriers of the CYP2D6 gene duplication may be at high risk for opioid adverse events. However, the effects of the CYP2D6 duplication on kinetics and dynamics of tramadol have not been systematically studied. Pharmacokinetics and effects were monitored after a single dose of 100 mg racemic tramadol in 11 carriers of a CYP2D6 gene duplication allele (ultrarapid metabolizer [UM]) and compared with 11 carriers of 2 active CYP2D6 genes (extensive metabolizer [EM]). Pharmacodynamics was measured by cold pressure test, pupillometry, and standardized adverse event recording. The maximum plasma concentrations of the active metabolite (+)R,R-O-desmethyltramadol were significantly higher in the UM group compared with the EM group (P = 0.005; t test) with a mean difference of 14 ng/mL (95% confidence limit of difference, 2-26 ng/mL). Median (+)R,R-tramadol area under the curve was 786 and 587 mug.h.L in EMs and UMs, and the corresponding median (+)R,R-O-desmethyltramadol area under the curve was 416 and 448 mug.h.L (P = 0.005, t test). There was an increased pain threshold and pain tolerance and a stronger ...Continue Reading

References

Oct 1, 1975·Clinical Pharmacology and Therapeutics·G R Wilkinson, D G Shand
Aug 1, 1992·The Clinical Investigator·W D PaarH J Dengler
Jul 1, 1973·Psychophysiology·E HoddesW C Dement
Mar 1, 1995·Clinical Pharmacology and Therapeutics·J A AgúndezJ Benítez
Dec 1, 1996·Clinical Pharmacology and Therapeutics·L PoulsenS H Sindrup
Jan 1, 1997·Drugs·P DayerL Collart
Jun 1, 1997·Pharmacogenetics·R A McLellanM Ingelman-Sundberg
Oct 24, 1997·The Annals of Pharmacotherapy·P P GleasonT O'Toole
Jan 1, 1997·European Journal of Clinical Pharmacology·W D PaarH J Dengler
May 20, 1998·Clinical Pharmacology and Therapeutics·P DalénL Bertilsson
Aug 25, 1999·Clinical Pharmacology and Therapeutics·A S AynaciogluJ Brockmöller
Jun 18, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rolf KaiserJürgen Brockmöller
Oct 2, 2002·Journal of Neurochemistry·Sharon MiksysRachel F Tyndale
Sep 23, 2003·Pain·Ulrike M StamerFrank Stuber
Nov 19, 2003·Metabolism: Clinical and Experimental·Jürgen BorlakThomas Thum
Sep 2, 2004·European Journal of Human Genetics : EJHG·Silvia FuselliGuido Barbujani
Dec 31, 2004·The New England Journal of Medicine·Yvan GascheJules Desmeules
Jan 18, 2005·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Huai-Rong LuoYu-Jui Yvonne Wan
Jun 18, 2005·Clinical Pharmacology and Therapeutics·Rasmus Steen PedersenKim Brosen
Dec 22, 2005·Anesthesia and Analgesia·Thomas P EnggaardSøren H Sindrup
Jun 10, 2006·European Journal of Clinical Pharmacology·Rasmus Steen PedersenKim Brøsen
Dec 19, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Emilio García-QuetglasMiguel Angel Campanero
May 2, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David Hallifax, J Brian Houston

❮ Previous
Next ❯

Citations

Jun 22, 2011·European Journal of Clinical Pharmacology·Ahmed ElkalioubieFrançois Fourrier
Nov 5, 2010·International Journal of Clinical Pharmacy·Bob WilffertUNKNOWN KNMP working group Pharmacogenetics
Mar 3, 2011·International Journal of Clinical Pharmacy·Bob WilffertUNKNOWN KNMP working group Pharmacogenetics
Apr 17, 2013·Molecular Diagnosis & Therapy·C F SamerJ A Desmeules
Dec 15, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Inger Johansson, Magnus Ingelman-Sundberg
Apr 16, 2011·Pharmacology·Wojciech Leppert
Aug 17, 2010·Journal of Perinatal Medicine·S HartensteinCharles Christoph Roehr
Apr 21, 2010·Pediatrics·Kanwaljeet J S AnandUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Resear
Jan 1, 2011·Pharmacogenomics and Personalized Medicine·Larisa H CavallariAdam Bress
Dec 12, 2012·Pharmacogenomics and Personalized Medicine·Pascal H VuilleumierRuth Landau
Oct 13, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Nov 12, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Jul 4, 2008·Pharmacogenomics·Victoria RollasonJules Desmeules
May 28, 2010·Pharmacogenomics·Ulrike M StamerFrank Stüber
Feb 2, 2011·American Journal of Veterinary Research·Butch Kukanich, Mark G Papich
Feb 13, 2014·Italian Journal of Pediatrics·Franca Benini, Egidio Barbi
Feb 19, 2014·Pharmacogenomics·Blanca Patricia Lazalde-RamosAdrián Llerena
Apr 9, 2014·Forensic Science International : Synergy·Salumeh BastamiSrinivas Uppugunduri
Dec 3, 2014·Journal of the American Veterinary Medical Association·Cherlene DelgadoLesley J Smith
Jun 22, 2012·Biological Research for Nursing·Susan W WesmillerYvette P Conley
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
May 23, 2015·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Vincent Haufroid, Philippe Hantson
Sep 11, 2010·Forensic Science International : Synergy·Frank MusshoffBurkhard Madea
Aug 17, 2010·Forensic Science International : Synergy·Maren Kleine-BrueggeneyUlrike M Stamer
Mar 17, 2010·Mayo Clinic Proceedings·Maija L HaanpääChristopher D Wells
Jul 21, 2009·Pharmacology & Therapeutics·Jörn LötschIrmgard Tegeder
Dec 2, 2015·Journal of Pharmaceutical and Biomedical Analysis·Pernilla HaageMartin Josefsson
Jun 6, 2009·Basic & Clinical Pharmacology & Toxicology·Mouna KanaanJules Desmeules
Oct 13, 2011·The Journal of Pharmacy and Pharmacology·Arjun Muralidharan, Maree T Smith
Jul 12, 2012·Clinical Genetics·M T Smith, A Muralidharan
Dec 11, 2014·Anaesthesia·B GibbisonA A Klein
Dec 10, 2014·Journal of Veterinary Pharmacology and Therapeutics·K R KellyK L Christe
Apr 26, 2015·Clinical Pharmacokinetics·Dorte LassenKim Brøsen
Jun 16, 2015·International Journal of Genomics·Eugenia Yiannakopoulou
Jan 25, 2014·Clinical Pharmacology and Therapeutics·K R CrewsUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Jul 9, 2016·Expert Opinion on Drug Metabolism & Toxicology·Tatiana TverdohlebNebojsa Nick Knezevic
Apr 3, 2016·Basic & Clinical Pharmacology & Toxicology·Paavo PietarinenMikko Niemi
Aug 16, 2016·Clinics in Laboratory Medicine·Lynn R Webster, Inna Belfer
Jun 2, 2009·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Lukás ChytilOndrej Slanar
Jul 12, 2017·Current Medical Research and Opinion·Joäo Batista Santos GarciaPatricia Bonilla Sierra
Jan 26, 2018·European Journal of Pain : EJP·J FariaR J Dinis-Oliveira
Dec 10, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·M Brooke BernhardtChris Glover

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.